Overview on Hormonal Replacement Therapy in Menopause
-
Published:2021-07-30
Issue:
Volume:
Page:141-147
-
ISSN:2456-9119
-
Container-title:Journal of Pharmaceutical Research International
-
language:
-
Short-container-title:JPRI
Author:
Alanazi Shaden Akram A.,Alatawi Atheer Mansour E.,Alhwaiti Atheer Salman A.,Alrashidi Aumniyat Saad A.,Alanazi Ghadah Ali R.,Alfaqiri Mei Khalid S.,Alenezi Rahaf Naif A.,Albalawi Wejdan Abdullah,Alharbi Layan Hussain J.,Alharbi Ghada Abdullah H.
Abstract
Hormone replacement therapy (HRT) is defined as a therapy that could allow women to free themselves from the malediction of estrogen loss and conserve their femininity. The study aims to summarize the updated evidence regards types, indication, contraindication, and untoward effects of hormonal replacement therapy among menopausal women. There are several different drug classes comprising estrogens, progestogens, and estrogen + progestogen combinations. Estrogen is the primary active component of HRT, treating menopausal symptoms, particularly vasomotor symptoms. There are several adverse effects of hormone replacement therapy that manifest in many different ways depending on the route of administration, and whether that route has local or systemic effects. Further research is needed to study the risks of menopausal HRT and pharmacological studies are needed to lower these risks and make its use safer with less side effects.
Publisher
Sciencedomain International